Approval · Notice of Compliance 29408 · 2022
ACULAR: Notice of Compliance 29408
Issued November 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29408
- Date
- November 8, 2022
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Merger/Buy-out
Products in this notice
Medicinal ingredients
- KETOROLAC TROMETHAMINE 0.5 PER
- KETOROLAC TROMETHAMINE 0.4 PER